FDA approves early, pre-approval trials for pediatric cases
Adalimumab may be effective for plaque psoriasis, but not heart disease and other inflammatory conditions associated with the condition. This study confirms that the inflammatory process is unique and that one treatment may not apply to other inflammatory conditions.
Review highlights the need to accurately diagnose this common bacterial infection.
The AMA’s chief information officer talks digital health technology with Dermatology Times.
There are two important reasons why physicians should consider the role of diet in triggering psoriasis flares, says a leading expert.
Pediatric melanomas are often misdiagnosed by physicians. Adolescents have a more aggressive disease course than children and are treated with adult protocols leading to chronic morbidity.
Oral propranolol may be safe for infants with uncomplicated hemangiomas, but for those with underlying health conditions, it may not always be the treatment of choice.
Observational study shows high heart disease risk in severe and predominantly active atopic eczema.
Skin biopsies from infants with atopic dermatitis feature important differences compared to adults with atopic dermatitis. These differences could change atopic dermatitis treatment for infants and toddlers with the disease, a study shows.
The fixed combination of halobetasol and tazarotene topicals significantly reduced the severity of localized disease with a favorable safety profile, shows a study published in the Journal of the American Academy of Dermatology.